AC Immune ACIU
NASDAQ ACIU
$2.81 +0.19 (+7.25%)
At close: Oct 1, 2026 · 4:00 PM EDT

AC Immune (ACIU) Accumulated Depreciation (2016 - 2017)

Updated

AC Immune (ACIU) posted Accumulated Depreciation of -$2.66 million for the quarter ended Sep 30, 2017.

Analysis

AC Immune (ACIU) Accumulated Depreciation (2016 - 2017) Analysis & Trends

As of Dec 31, 2016, AC Immune's Accumulated Depreciation came in at -$2.19 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 AC Immune 266.56 Mn 266.56 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -2.66 Mn
Dec 31, 2016 -2.16 Mn
API Access

AC Immune Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=ACIU&period=max&api_key=YOUR_API_KEY